A Detail View of Single-Use Equipment Opportunities - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A Detail View of Single-Use Equipment Opportunities
The authors propose increased use of single-use technologies in biopharmaceutical manufacturing to achieve operational excellence without compromising product quality.


Pharmaceutical Technology
Volume 34, pp. s16-s20

Technology-integration improvements

The "single-use" concept came loaded with huge expectations of finding new solutions to address the needs of the changing biopharmaceutical industry. Suppliers of single-use equipment have had difficulty living up to these expectations thus far, partly because the expectations were not properly defined and partly due to intellectual property (IP) and supply-chain issues.


Figure 3: Water-consumption percentage differences: Stainless steel versus single-use equipment (Data from Ref. 9).
In a hard-piped manufacturing process, the bioprocessing flow path is only qualified once. With single-use technology, a new flow path might be supplied various times, especially in multipurpose scenarios, and the qualification of the new flow's components is often in the hands of the supplier. The supplier is urged to provide disposable flow paths using the same components and properties for years to come.

To meet this request, however, the supplier must own all of the critical pieces of a particular assembly. For this reason, many suppliers are aligning with, or acquiring, component suppliers and IP owners. Unfortunately, a lack of standards and competition in this arena has promoted a vast array of equipment items, assemblies, and validation-procedure differences. These varieties, marketing-driven product and validation claims cause more insecurities and questions, than solid standardized solutions.

Promising new development, in the form of single-use unit operations, is moving away from isolated technical solutions and toward new, highly-integrated concepts. End-users of disposable bags for media initiated this trend in an effort to move from a fixed process to a single-use process that includes mixing, filtration, temperature, recipe, and level control.

The integration of disposable sensors helped develop fully-disposable, cell-culture systems and opened the door for single-use applications for most of the unit operations within a manufacturing process. New approaches are supplying single-use technology platforms along the typical manufacturing process.

The application know-how determines the design of those platforms, but standardization of components such as tubing and connectors, ensures interconnectivity at the same time. These concepts allow a clean and streamlined process with a unified automation, control, and validation concept and, finally, a high level of operational excellence and security.

The single-use approach demands the highest level of technology integration possible. However, the economic and operational advantages of the disposable option apply mostly to Green Field Facilities (i.e., facilities planned from scratch) with high-value, low-volume products and might not be an option for existing manufacturing processes. This restriction to new facility design is a purely economical one as most of the capital investments within existing processes are made and the equipment is written off. Nevertheless, the flexibility of single-use manufacturing philosophy is attractive for expansion projects within existing facilities. In addition, so-called "hybrid" systems merge the best out of both worlds by integrating single-use unit operations such as buffer and media-hold steps, into existing production facilities.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here